Eric S. Winer

Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study

H. Safran, B. Karaszewska, S. Bauer, 2017, International Journal of Hematology.

A genetic linkage map of the laboratory rat, Rattus norvegicus

M. Daly, E. Lander, Å. Lernmark, 1995, Nature Genetics.

Ixazomib, Oral Metronomic Cyclophosphamide, and Dexamethasone for First-Line Treatment of Multiple Myeloma: A Phase II Brown University Oncology Group Study

J. Reagan, A. Olszewski, Peter Barth, 2023, The oncologist.

Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.

D. DeAngelo, Jacqueline S. Garcia, M. Wadleigh, 2023, Leukemia research.

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia

J. Butera, F. Claas, P. Quesenberry, 2015, Blood Cancer Journal.

Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study.

A. Goldberg, H. Kantarjian, G. Garcia-Manero, 2023, The Lancet. Haematology.

Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features, but share ancestral clonal mutations with bone marrow.

Scott B. Lovitch, R. Hasserjian, O. Pozdnyakova, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.

Traci M. Blonquist, D. Neuberg, T. Graubert, 2019, The Lancet. Haematology.